Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Down 25.0% in August

Starpharma Holdings Limited (OTCMKTS:SPHRY) saw a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 2,700 shares, a drop of 25.0% from the August 15th total of 3,600 shares. Based on an average daily trading volume, of 700 shares, the days-to-cover ratio is currently 3.9 days.

Starpharma Trading Up 14.0 %

Shares of Starpharma stock opened at $0.65 on Monday. Starpharma has a fifty-two week low of $0.52 and a fifty-two week high of $1.33. The firm has a 50-day simple moving average of $0.58 and a two-hundred day simple moving average of $0.72.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.